EUVIMEDEUVIMED entdecken
Crossref

Effect of rimonabant on the components of metabolic syndrome: A randomized, controlled study done on Punjabi population

Rupinderjeet Kaur, Amarpreet Kaur, Harharpreet Kaur, DevinderS Mahajan, Paramdeep Singh

Journal of Pharmaceutical Negative Results · 2013

DOI: 10.4103/0976-9234.116765 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Pharmaceutical Negative Results, 2013. Verfasst von Rupinderjeet Kaur und 4 weiteren Autor:innen. Die Arbeit wurde bisher 2-mal zitiert (Crossref).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The objectives of this study were to study the total and differential effect of Rimonabant onweight parameters, lipid profile, glycemic profile, and blood pressure and to evaluate its safetyprofile in obese population of Punjab. Materials and Methods: This was a randomized opencontrolled study, carried out on 100 subjects that included Punjabi adults (18‑70 years)who were obese or overweight (with associated risk factors) according to Asia pacificguidelines. Treatment group (n = 50) was given Rimonabant 20 mg once‑daily, and controlgroup (n = 50) was given placebo for 12 weeks. Alterations in weight and lipid parameters,Fasting blood sugar(FBS), and blood pressure were recorded. Psychiatric adverse events weremonitored by HADS score. Analysis was done using SPSS software.

Results

Statisticallysignificant difference was observed in two groups in reduction in weight, waist circumference,body mass index. Overall reduction in number of patients in the obese category was 20% ingroup 1 and 6.25% in group 2. In lipid parameters, significant changes were observed intriglycerides (TG), HDL cholesterol, and total cholesterol: HDL ratio (P < 0.001). Nosignificant change was observed for LDL cholesterol and total cholesterol. Effect on FastingBlood Sugar (FBS) was also significant. Moderate decrease in systolic blood pressure andno significant change was observed in diastolic blood pressure. Using multivariate regressionmodel, Rimonabant was found to have weight‑loss independent effect on lipid parameterswith triglycerides having the maximum percentage difference between regression coefficients.No significant correlation was observed between changes in lipid parameters and weight loss.Amongst the lipids, changes in triglycerides and HDL cholesterol correlated best. Decreasein FBS correlated with weight loss but not to lipid parameters. Adverse event profile wascomparable in both groups. Depressive symptoms were noted in 3 subjects in treatmentgroup with 1 requiring termination of treatment. Frequency of anxiety symptoms was samein both groups with none showing tendency towards suicide.

Conclusions

This is thefirst study of Rimonabant on Punjabi population and reports the depressive adverse eventsto be occurring in low frequency and of mild intensity in this group. Thus, it provides aclue to the need for further studies of cannabinoid receptor antagonists on larger samplesin such ethnically predisposed populations to reevaluate the safety profile and its geneticcorrelation. It also suggests need for further research on differential effect of antagonism ofcannabinoid receptors in CNS and adipose tissue and its use to produce drug that targetsmetabolic derangements by selective action on adipose tissue receptors.

Zitieren

APA

Kaur, R., Kaur, A., Kaur, H., Mahajan, D., & Singh, P. (2013). Effect of rimonabant on the components of metabolic syndrome: A randomized, controlled study done on Punjabi population. Journal of Pharmaceutical Negative Results. https://doi.org/10.4103/0976-9234.116765

Vancouver

Kaur R, Kaur A, Kaur H, Mahajan D, Singh P. Effect of rimonabant on the components of metabolic syndrome: A randomized, controlled study done on Punjabi population. Journal of Pharmaceutical Negative Results. 2013. doi:10.4103/0976-9234.116765

BibTeX
@article{Kaur2013,
  author = {Kaur, Rupinderjeet and Kaur, Amarpreet and Kaur, Harharpreet and Mahajan, DevinderS and Singh, Paramdeep},
  title = {Effect of rimonabant on the components of metabolic syndrome: A randomized, controlled study done on Punjabi population},
  journal = {Journal of Pharmaceutical Negative Results},
  year = {2013},
  doi = {10.4103/0976-9234.116765}
}
Kostenlos starten →